Merck
Budget
€1 — €750
EP Access
6
accredited persons
Staff
10
4.45 FTE
EU Grants
None
Mission & Goals
Merck, a leading science and technology company, generated total revenues of €22,2 billion in 2022 with its divisions Healthcare, Electronics and Life Science. More than 64,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent stakes, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are the United States and Canada. Here Merck operates as EMD Serono in the Biopharma business, MilliporeSigma in the Life Science business, and as EMD Performance Materials in the Performance Materials/Electronics business.
EU Legislative Interests
Clean Industrial Deal, EU Economic Security Strategy, EU Competitiveness, Single Market Completion and all relevant policies/initiatives such as: Chemicals Strategy for Sustainability - REACH revision, Industrial Emissions Directive, Clean Air and Water, Fit-for-55, CLP regulation, Circular Economy policies, PFAS, CBAM Raw-Materials Act Digital Policies (i.e. EU Chips-Act, EU AI Act, EHDS) Trade policies (eg Global Gateway, customs regulations, TTC developments) Sustainable Finance (eg Taxonomy) Omnibuses for simplification Pharmaceutical Strategy and Health Care related policies. Intellectual Property (IP) Package Life Science related policies such as Medicinal Products Directive. Alternative approached to Animal testing Sanctions Packages on Russia etc.
Communication Activities
2024: Sponsoring of a Talk in Brussels on the topic of EU Competitiveness, with representatives of EU parliament, EU Commission and other stakeholders.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Merck is a member of CEFIC (EU), EFPIA (EU), EBE - European Biopharmaceutical Enterprises (EU), EuropaBio, BVAC (DE with EU-office), VCI (DE) and its sub-state organisations such as LV Hessen, and DIB (Deutsche Industrievereinigung Biotechnologie), Bundesverband der deutschen Industrie (BDI), Verband forschender Arzneimittelhersteller (DE), World Economic Forum (WEF), Bitkom (DE), European Round Table for Industry (ERT), Cosmetics Europe, EUCCC (European Chamber of Commerce), ACATECH and various other sectoral organisations mainly at respective national/regional levels in the countries such as European General Counsel Association (UK), European Process Safety Center (UK), European Centre for Ecotoxicology and Toxicology of Chemicals (BE), European Partnership for Alternative Approaches to Animal testing (EPAA)
Organisation Members
see above
Additional Information
Costs increased in 2024 due to the high number of important files that required more work with EU Institutions (General Pharmaceutical Legislation, Green Deal, PFAS, Chips and AI,...), and post-election intensive activities
Commissioner Meetings
No recorded meetings with EU commissioners.